Company Directory / research
PrivateFor profitresearchCambridge, United States
Faze Medicines
Faze Medicines is a biotechnology company.
- Founded
- 2020 6 years ago
- Staff
- 11-50 band, as listed
- Followers
- - on LinkedIn
- Funding
- $81M as listed, currency not stated
Set against six million companies
Size
11-50 people: larger than 33% of companies with a size listed
Age
6 years old.
Reach
No web traffic ranking listed.
What it does
BiotechnologyChemical
Funding, as listed
$81M currency not stated
- Rounds1
- LatestSeries a, Dec 2020
- Investors8, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Faze Medicines, field by field. Contact details are held but never shown.
The company
- Name
- Faze Medicines
- Type
- For profit
- Status
- Private
- Founded
- 2020
- Founders
- J. Paul Taylor, Mike Rosen, Ron Vale, Roy Parker
- Industry
- research
- Categories
- Biotechnology, Chemical
Where
- City
- Cambridge
- Country
- United States
- Markets
- Greater Boston Area, East Coast, New England, Northeastern US
Size and reach
- Staff band
- 11-50
Funding, as listed
- Total
- 81,000,000 (currency not stated)
- Rounds
- 1
- Latest round
- Series a
- Latest round date
- Dec 2020
- Investors
- 8
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Companies like it
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.